Literature DB >> 1085925

Risk of combination of tri-acetyl-oleandomycin and ergotamine tartrate.

H Lesca, D Ossard, P Reynier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1085925

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN： 0301-1518


× No keyword cloud information.
  3 in total

Review 1.  Clinically significant drug interactions with agents specific for migraine attacks.

Authors:  M J Eadie
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Side-effects due to the intravenous infusion of erythromycin lactobionate.

Authors:  R Putzi; J Blaser; R Lüthy; R Wehrli; W Siegenthaler
Journal:  Infection       Date:  1983 May-Jun       Impact factor: 3.553

3.  Severe vascular spasm due to erythromycin-ergotamine interaction.

Authors:  H Francis; A Tyndall; J Webb
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.